{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:21:19Z","timestamp":1792797679473,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.ejmech.2013.09.009","type":"journal-article","created":{"date-parts":[[2013,9,18]],"date-time":"2013-09-18T16:16:49Z","timestamp":1379521009000},"page":"480-489","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Design, synthesis and biological evaluation of WC-9 analogs as\u00a0antiparasitic agents"],"prefix":"10.1016","volume":"69","author":[{"given":"Pablo D.","family":"Elicio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda N.","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melina","family":"Galizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio H.","family":"Szajnman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Docampo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia N.J.","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan B.","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2013.09.009_bib1","doi-asserted-by":"crossref","first-page":"882","DOI":"10.2174\/138161208784041079","article-title":"The acidocalcisome as a target for chemotherapeutic agents in protozoan parasites","volume":"14","author":"Docampo","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejmech.2013.09.009_bib2","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.pt.2003.09.001","article-title":"Specific chemotherapy of Chagas' disease: controversies and advances","volume":"19","author":"Urbina","year":"2003","journal-title":"Trends Parassitol."},{"key":"10.1016\/j.ejmech.2013.09.009_bib3","unstructured":"www.who.int\/topics\/tropical_diseases\/en\/."},{"key":"10.1016\/j.ejmech.2013.09.009_bib4","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1146\/annurev.mi.27.100173.002023","article-title":"Biology of Trypanosoma cruzi","volume":"27","author":"Brener","year":"1973","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2013.09.009_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-385863-4.00001-0","article-title":"Epidemiology of American trypanosomiasis (Chagas disease)","volume":"75","author":"Kirchhoff","year":"2011","journal-title":"Adv. Parasitol."},{"key":"10.1016\/j.ejmech.2013.09.009_bib6","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1056\/NEJM199308263290909","article-title":"American Trypanosomiasis (Chagas' Disease) \u2013 a tropical disease now in the United States","volume":"329","author":"Kirchhoff","year":"1993","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2013.09.009_bib7","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1517\/14728222.12.3.253","article-title":"Targeting the isoprenoid pathway of Toxoplasma gondii","volume":"12","author":"Moreno","year":"2008","journal-title":"Expert Opinion. Ther. Targets"},{"key":"10.1016\/j.ejmech.2013.09.009_bib8","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1517\/13543776.2012.668886","article-title":"New antibacterials for the treatment of toxoplasmosis; a patent review","volume":"22","author":"Rodriguez","year":"2012","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2013.09.009_bib9","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1128\/CMR.11.2.267","article-title":"Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts","volume":"11","author":"Dubey","year":"1998","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2013.09.009_bib10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.actatropica.2009.10.023","article-title":"Specific chemotherapy of Chagas disease: relevance, current limitations and new approaches","volume":"115","author":"Urbina","year":"2010","journal-title":"Acta Trop."},{"key":"10.1016\/j.ejmech.2013.09.009_bib11","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1358\/dof.2010.035.05.1484391","article-title":"New insights in Chagas disease treatment","volume":"35","author":"Urbina","year":"2010","journal-title":"Drugs Fut."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.ejmech.2013.09.009_bib12","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1590\/S0074-02761999000700068","article-title":"Parasitological cure of Chagas disease: is it possible? Is it relevant?","volume":"94","author":"Urbina","year":"1999","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.ejmech.2013.09.009_bib13","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2174\/1568005013343191","article-title":"Bisphosphonates as chemotherapeutic agents against trypanosomatid and apicomplexan parasites","volume":"1","author":"Docampo","year":"2001","journal-title":"Curr. Drug Targets Infect. Disord."},{"key":"10.1016\/j.ejmech.2013.09.009_bib14","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0166-6851(02)00282-7","article-title":"Protein farnesyl and N-myristoyl transferases: piggy-back medicinal chemistry targets for the development of antitrypanosomatid and antimalarial therapeutics","volume":"126","author":"Gelb","year":"2003","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ejmech.2013.09.009_bib15","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0014-5793(03)00483-6","article-title":"Microbial isoprenoid biosynthesis and human gammadelta T cell activation","volume":"544","author":"Eberl","year":"2003","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejmech.2013.09.009_bib16","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1021\/cr60276a002","article-title":"The biosynthesis of monoterpenes","volume":"72","author":"Banthorpe","year":"1972","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2013.09.009_bib17","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1084\/jem.20110039","article-title":"Apicoplast isoprenoid precursor synthesis and the molecular basis of fosmidomycin resistance in Toxoplasma gondii","volume":"208","author":"Nair","year":"2011","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ejmech.2013.09.009_bib18","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1017\/S0031182097001194","article-title":"Lipid biosynthesis pathways as chemotherapeutic targets in kinetoplastid parasites","volume":"117","author":"Urbina","year":"1997","journal-title":"Parasitology"},{"key":"10.1016\/j.ejmech.2013.09.009_bib19","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/00001432-200112000-00012","article-title":"Specific treatment of Chagas disease: current status and new developments","volume":"14","author":"Urbina","year":"2001","journal-title":"Curr. Op. Infect. Dis."},{"key":"10.1016\/j.ejmech.2013.09.009_bib20","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2174\/1381612023396177","article-title":"Chemotherapy of Chagas disease","volume":"8","author":"Urbina","year":"2002","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejmech.2013.09.009_bib21","doi-asserted-by":"crossref","first-page":"3984","DOI":"10.1021\/jm0201518","article-title":"Design, synthesis and biological evaluation of aryloxyethyl thiocyanate derivatives against Trypanosoma cruzi","volume":"45","author":"Elhalem","year":"2002","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.009_bib22","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1021\/jm9905007","article-title":"Design and synthesis of aryloxyethyl thiocyanate derivatives as potent inhibitors of Trypanosoma cruzi proliferation","volume":"43","author":"Szajnman","year":"2000","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.009_bib23","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1021\/jm970860z","article-title":"Structure\u2013activity relationship of new growth inhibitors of Trypanosoma cruzi","volume":"41","author":"Cinque","year":"1998","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.009_bib24","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1128\/AAC.47.6.2047-2050.2003","article-title":"Mechanism of action of 4-phenoxyphenoxy derivatives against Trypanosoma cruzi, the causative agent of Chagas disease","volume":"47","author":"Urbina","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2013.09.009_bib25","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1006\/abbi.1998.0577","article-title":"3-Hydroxy-3-methyl-glutaryl-CoA reductase in Trypanosoma (Schizotrypanum) cruzi: subcellular localization and kinetic properties","volume":"352","author":"Concepcion","year":"1998","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejmech.2013.09.009_bib26","doi-asserted-by":"crossref","first-page":"8846","DOI":"10.1021\/ja020411a","article-title":"Recombinant squalene synthase. A mechanism for the rearrangement of presqualene diphosphate to squalene","volume":"124","author":"Blagg","year":"2002","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2013.09.009_bib27","doi-asserted-by":"crossref","first-page":"8834","DOI":"10.1021\/ja020410i","article-title":"Recombinant squalene synthase. Synthesis of non-head-to-tail isoprenoids in the absence of NADPH","volume":"124","author":"Jarstfer","year":"2002","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2013.09.009_bib28","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1021\/jm950907l","article-title":"Synthesis and activity of a novel series of 3-biarylquinuclidine squalene synthase inhibitors","volume":"39","author":"Brown","year":"1996","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.009_bib29","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/sj.bjp.0703545","article-title":"YM-53601, a novel squalene synthase inhibitor, reduces plasma cholesterol and triglycerides in several animal species","volume":"131","author":"Ugawa","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2013.09.009_bib30","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1083\/jcb.149.1.167","article-title":"Toxoplasma gondii exploits host low-density lipoprotein receptor-mediated endocytosis for cholesterol acquisition","volume":"149","author":"Coppens","year":"2000","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.ejmech.2013.09.009_bib31","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1021\/jm9607616","article-title":"Design, synthesis and biological evaluation of new growth inhibitors of Trypanosoma cruzi (epimastigotes)","volume":"40","author":"Schvartzapel","year":"1997","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.009_bib32","doi-asserted-by":"crossref","first-page":"5068","DOI":"10.1016\/j.bmcl.2007.07.012","article-title":"Fluorine-containing aryloxyethyl thiocyanate derivatives are potent inhibitors of Trypanosoma cruzi and Toxoplasma gondii proliferation","volume":"17","author":"Garc\u00eda Li\u00f1ares","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2013.09.009_bib33","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2174\/092986706775476043","article-title":"Progresses in the field of drug design to combat tropical protozoan parasitic diseases","volume":"13","author":"Garc\u00eda Li\u00f1ares","year":"2006","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.009_bib34","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1016\/S0040-4039(98)00502-4","article-title":"Synthesis of diaryl ethers through the copper-promoted arylation of phenols with arylboronic acids. An expedient synthesis of thyroxine","volume":"39","author":"Evans","year":"1998","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2013.09.009_bib35","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1016\/S0040-4039(98)00503-6","article-title":"New N- and O-arylations with phenylboronic acids and cupric acetate","volume":"39","author":"Chan","year":"1998","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2013.09.009_bib36a","doi-asserted-by":"crossref","first-page":"17423","DOI":"10.1021\/ja9081815","article-title":"Orthogonal Cu- and Pd-based catalyst systems for the O- and N-arylation of aminophenols","volume":"131","author":"Maiti","year":"2009","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2013.09.009_bib36b","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1021\/ol9015892","article-title":"A\u00a0versatile catalyst system for Suzuki\u2013Miyaura cross-coupling reactions of C(sp2)-tosylates and mesylates","volume":"11","author":"Bhayana","year":"2009","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2013.09.009_bib36c","doi-asserted-by":"crossref","first-page":"13552","DOI":"10.1021\/ja8055358","article-title":"A\u00a0highly active catalyst for Pd-catalyzed amination reactions: cross-coupling reactions using aryl mesylates and the highly selective monoarylation of primary amines using aryl chlorides","volume":"130","author":"Fors","year":"2008","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2013.09.009_bib37","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.1021\/jm300208p","article-title":"Head-to-head prenyl transferases: anti-infective drug targets","volume":"55","author":"Lin","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.09.009_bib38","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1002\/hlca.19950780513","article-title":"Design, synthesis and anti-Trypanosoma cruzi evaluation of a new class of cell growth inhibitors structurally related to fenoxycarb","volume":"78","author":"Schvartzapel","year":"1995","journal-title":"Helv. Chim. Acta"},{"key":"10.1016\/j.ejmech.2013.09.009_bib39","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1128\/AAC.38.5.1144","article-title":"3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors lovastatin and simvastatin inhibit in\u00a0vitro development of Plasmodium falciparum and Babesia divergens in human erythrocytes","volume":"38","author":"Grellier","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2013.09.009_bib40","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1128\/AAC.01330-06","article-title":"Atorvastatin is 10-fold more active in\u00a0vitro than other statins against Plasmodium falciparum","volume":"51","author":"Pradines","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2013.09.009_bib41","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1128\/AAC.02460-12","article-title":"Drug repurposing screen reveals FDA-approved inhibitors of human HMG-CoA reductase and isoprenoid synthesis that block Cryptosporidium parvum growth","volume":"57","author":"Bessoff","year":"2013","journal-title":"Antimcrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2013.09.009_bib42","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ijantimicag.2008.07.026","article-title":"Statins inhibit Toxoplasma gondii multiplication in macrophages in\u00a0vitro","volume":"33","author":"Cortez","year":"2009","journal-title":"Int. J. Antimcrob. Agents"},{"key":"10.1016\/j.ejmech.2013.09.009_bib43","doi-asserted-by":"crossref","first-page":"e740","DOI":"10.1371\/journal.pntd.0000740","article-title":"In\u00a0vitro and in\u00a0vivo high-throughput assays for the testing of anti-Trypanosoma cruzi compounds","volume":"4","author":"Canavaci","year":"2010","journal-title":"PLOS Negl. Trop. Dis."},{"key":"10.1016\/j.ejmech.2013.09.009_bib44","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1128\/AAC.47.1.309-316.2003","article-title":"High-throughput growth assay for Toxoplasma gondii using yellow fluorescent protein","volume":"43","author":"Gubbels","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2013.09.009_bib45","doi-asserted-by":"crossref","first-page":"33683","DOI":"10.1074\/jbc.M109.044024","article-title":"Genetic evidence that an endosymbiont-derived endoplasmic reticulum-associated protein degradation (ERAD) system functions in import of apicoplast proteins","volume":"284","author":"Agrawal","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2013.09.009_bib46","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ejmech.2012.12.015","article-title":"Design, synthesis and biological evaluation of sulfur-containing 1,1-bisphosphonic acids as antiparasitic agents","volume":"60","author":"Recher","year":"2013","journal-title":"Eur. J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523413005813?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523413005813?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T07:26:25Z","timestamp":1596525985000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523413005813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":48,"alternative-id":["S0223523413005813"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2013.09.009","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and biological evaluation of WC-9 analogs as\u00a0antiparasitic agents","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2013.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}